2013 - PhD Drug delivery and Biomaterials, Royal College of Surgeons in Ireland
2009 - BSc (Hons) Pharmacology, National University of Ireland
Dr Hastings is currently a publishing editor at the Royal Society of Chemistry, Cambridge, where he edits and proofreads scientific manuscripts and oversees the peer review process for two journals. While completing his PhD, Dr Hastings was awarded a 5-month research fellowship placement at the Wyss Institute at Harvard University. His doctoral research focused on injectable hydrogels for the delivery of small molecule drugs, growth factors or cells for the treatment of a variety of disease states, including solid tumors, myocardial infarction and critical limb ischemia. Following his PhD, Dr Hastings undertook a postdoctoral position on the AMCARE project, where his work focused on combining medical devices with cell and growth factor therapy as a regenerative treatment strategy for myocardial infarction. He has presented his research at international conferences, acted as a peer reviewer and has published seven articles in peer-reviewed journals. Dr Hastings joined Edanz Group as an editor in 2016.